Ansell buying single-use-glove maker BarrierSafe; FDA forced to act on triclosan;

> A lawsuit will force the FDA to take some action toward regulating triclosan, an endocrine-disrupting chemical that is widely used in antimicrobial soaps sold in the U.S. Release

> Clondalkin Pharma & Healthcare Guaynabo says it has created a new premium pack using highly technical printing techniques for a Pfizer ($PFE) Consumer Healthcare Advil product. Report

> Areva Med has started to extract and purify lead-212 for nuclear medicine use at a plant in Bessines-sur-Gartempe, France. Report

> Australia's Ansell, a maker of single-use gloves, is buying U.S.-based competitor BarrierSafe Solutions International for about $615 million. Story

And Finally... The Canadian Supreme Court upheld an Ontario provincial law banning store-brand generic drug products, agreeing that they were designed to keep prices of generics elevated. Story | More